Because tight junctions between the arachnoid barrier cells create a BCSF barrier that exhibits selective impermeability to immune cells and macromolecules, the changes in solute carrier genes, including SLC26A2 and SLC2A3, identified in our study indicate altered BCSF barrier function in AD. This evidence concerns the gene SLC2A3 and Alzheimer disease.